trending Market Intelligence /marketintelligence/en/news-insights/trending/IbgUMH6ChW5_WbHK3nBrQw2 content esgSubNav
In This List

DiaMedica completes placement of units

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


DiaMedica completes placement of units

DiaMedica Therapeutics Inc. completed a nonbrokered private placement of 3,624,408 units, raising gross proceeds of about C$1.2 million.

Each unit comprises 1 common share and a 24-month warrant to buy 1 common share for 35 U.S. cents.

The company will use proceeds to support the phase 2 clinical development of DM199 for acute ischemic stroke as well as for other working capital purposes.